MUTARS Segmental Prostheses
These devices are not cleared by the FDA for use in the US.
Over 20,000 MUTARS prostheses have been implanted since the debut of the system in 1992. A collaboration between implantcast and the University of Münster, the Modular Universal Tumor and Revision System was developed to treat major osseous defects of lower and upper extremities. The system has expanded and improved over the years as implantcast has incorporated options for increased indications as well as coating technologies.
Select a Solution Below